Major Salivary Gland Cancer TNM Staging (Pathological)

pTNM Staging | AJCC 2017

About

The TNM staging system anatomically classifies malignancies based on the extent of the primary tumour, regional lymph node involvement, and distant metastases. Staging helps physicians decide eligibility for clinical trials, define a patient's prognosis, and determine best treatment options.

The American Joint Committee on Cancer (AJCC) publishes the AJCC Cancer Staging Manual every 6-8 years. This tool is based on the 8th edition (2017) which represents the most up to date TNM staging guide.

References

American Joint Committee on Cancer (AJCC).

8th edition. New York: Springer; 2017.

By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.

1. Primary Tumour (T)

More Information

*Extraparenchymal extension is clinical or macroscopic evidence of invasion of soft tissues. Microscopic evidence alone does not constitute extraparenchymal extension for classification purposes

0/3 completed